“So if you're saying the former, I say you have been disingenuous all this time. You're implying that there may be something fundamentally wrong with Dr. BP's work!”

I’m not denying what the lab work by Dr. BP has shown, but that lab work needs to correlate to positive clinical outcomes in the M2M and severe trials. We know from the anecdotal EIND data that patients have clinically improved, but the placebo controlled, blinded trials most prove that. This is a biotech and nothing is sure until the data and FDA say so.